Malaria is the world's most important tropical parasitic disease and there
are an estimated 300-500 million cases of malaria each year. The emergence
of multi-drug resistant strains of the parasite is exacerbating the situati
on. Febrifugine, which was isolated from Dichroa febrifuga and Hydrangea um
bellata along with isofebrifugine, is a well-known candidate of antimalaria
l agent. The plane structure of febrifugine and isofebrifugine was first pr
oposed in 1950. Subsequently, their relative and absolute structures were p
roposed, based on Baker's synthetic work. The relative configuration of feb
rifugine was corrected in 1973 and then the absolute structures of febrifug
ine and isofebrifugine were corrected in 1999. These repeated errors and co
rrections have caused much confusion in the study of the relationship betwe
en the structure and antimalarial activity of febrifugine derivatives. Howe
ver, investigation of the antimalarial activity of febrifugine derivatives
is beginning anew, since it was reported that febrifugine had higher activi
ty than clinically used antimalarial drugs, and a derivative more potent th
an febrifugine was found.